1-1 of 1
Keating Michael, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Eradication of Minimal Residual Disease (MRD) in Patients with Hairy Cell Leukemia (HCL) after Cladribine (2CDA) Followed by an Extended Course of Rituximab.

Farhad Ravandi-Kashani, MD, Susan O’Brien, MD, Keating Michael, MD, Dan Jones, MD, Stefan Faderl, MD, Alessandra Ferrajoli, MD, William Wierda, MD, Shirley Odinga, Sherry Pierce, Charles Koller, MD, Srdan Verstovsek, MD, Jeffrey Jorgensen, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2005) 106 (11): 3258.
https://doi.org/10.1182/blood.V106.11.3258.3258
Published: 2005